Earnings History Data for Alaunos Therapeutics, Inc. (TCRT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Alaunos Therapeutics, Inc.
Alaunos Therapeutics Inc. is a clinical-stage oncology-focused cell therapy company. It focused on developing T-cell receptor therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform. Alaunos Therapeutics Inc., formerly known as Ziopharm Oncology Inc., is based in HOUSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2023 | PM | TCRT | Alaunos Therapeutics, Inc. | 23.49 | -0.04 | -0.03 | -0.04 | Alaunos Therapeutics GAAP EPS of -$0.04 in-line [11/14/2023 7:44 AM] |
0.0752 | -0.01 (-9.51%) |
0.09 | 0.0 (6.02%) |
0.07 - 1.09 | 9,425,763 | 2,560,000 | 26,986,800 | ||
| 14-08-2023 | AH | TCRT | Alaunos Therapeutics | 98.00 | -0.04 | -0.04 | 0.00 | Alaunos Therapeutics GAAP EPS of -$0.04 in-line [8/14/2023 4:59 PM] |
0.14 | -0.25 (-64.43%) |
0.19 | -0.20 (-50.53%) |
0.12 - 4.01 | 15,373,085 | 1,010,000 | 793,302 | ||
| 10-05-2023 | PM | 7:00 AM ET (May 10) |
TCRT | Alaunos Therapeutics, Inc. | 144.14 | -0.04 | -0.04 | -0.05 | Alaunos Therapeutics GAAP EPS of -$0.04 in-line [5/10/2023 7:09 AM] |
0.6199 | 0.02 (3.49%) |
0.0 | 0.0 (0.00%) |
0.45 - 4.01 | 516,547 | 450,000 | 0 | |
| 07-03-2023 | PM | 7:00 AM ET (Mar 7) |
TCRT | Alaunos Therapeutics, Inc. | 143.24 | -0.04 | -0.09 | -0.05 | Alaunos Therapeutics GAAP EPS of -$0.04 beats by $0.03 [3/7/2023 7:03 AM] |
0.60 | 0.02 (3.75%) |
0.56 | -0.02 (-2.75%) |
0.41 - 4.01 | 1,701,067 | 660,000 | 21,243 | |
| 14-11-2022 | PM | 7:00 AM ET (Nov 14) |
TCRT | Alaunos Therapeutics, Inc. | 231.31 | -0.04 | -0.12 | -0.11 | Alaunos Therapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $2.9M [11/14/2022 7:02 AM] |
1.00 | -0.08 (-7.40%) |
1.07 | -0.01 (-0.93%) |
0.41 - 4.01 | 1,152,911 | 1,130,000 | 111,537 | |
| 15-08-2022 | PM | 7:30 AM ET (Aug 15) |
TCRT | Alaunos Therapeutics, Inc. | 256.98 | -0.05 | -0.11 | -0.11 | Alaunos Therapeutics GAAP EPS of -$0.05 beats by $0.02 [8/15/2022 7:16 AM] |
3.76 | -0.21 (-5.29%) |
1.70 | 0.05 (3.03%) |
3.68 - 12.42 | 14,481 | 20,000 | 37,245 | |
| 16-05-2022 | PM | 7:30 AM ET (May 16) |
TCRT | Alaunos Therapeutics, Inc. | 125.81 | -0.05 | -0.09 | -0.10 | Alaunos Therapeutics GAAP EPS of -$0.05 beats by $0.02 [5/16/2022 7:31 AM] |
0.5042 | -0.09 (-14.54%) |
0.59 | 0.0 (0.00%) |
0.41 - 3.73 | 1,708,865 | 3,150,000 | 14,546 | |
| 30-03-2022 | PM | Before the open (Mar 30) |
TCRT | Alaunos Therapeutics, Inc. | 142.01 | -0.05 | -0.09 | -0.11 | Alaunos Therapeutics GAAP EPS of -$0.05 beats by $0.03 [3/30/2022 7:35 AM] |
0.6764 | -0.02 (-2.55%) |
0.74 | 0.04 (5.89%) |
0.60 - 3.80 | 1,255,787 | 3,220,000 | 39,119 | |